Plasma Cell Dyscrasias Unit, Alexandra General Hospital DAC

Dr Tina Bagratuni
tbagratuni@med.uoa.gr

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000001776	We performed whole-exome sequencing on Bone-Marrow and Peripheral Blood samples from WM patients, including 9 patients with sequential samples.	Illumina NovaSeq 6000	229
EGAD50000002267	In this data, we investigate the complex interplay between tumour-acquired genetic features and the composition of the microenvironment in the promotion of ibrutinib resistance in WM patients by integrating single-cell RNA sequencing (scRNAseq) and whole-genome sequencing (WGS), to examine bone marrow tumour and immune compartments from 37 symptomatic WM patients treated with ibrutinib.	Illumina NovaSeq 6000	137